The Food and Drug Administration Warns Liver Injuries Possible
The United States Food and Drug Administration (FDA) has announced that it discovered cases of liver injury among patients taking Amgen’s drug for a group of rare autoimmune diseases. The FDA asked healthcare providers to stop using this treatment if there’s a suspicion of organ injury or damage. If you were injured as a result of taking the Amgen drug—Tavneos—you should consult the seasoned Chicago-based lawyers of Moll Law Group. We represent clients around the country, and billions have been recovered in cases with which we’ve were involved.
Call Moll Law Group About Your Amgen Claim
In its announcement, the agency stated that it had identified 76 instances of drug-induced liver injury and among those, eight deaths. The evidence suggests that these injuries may be caused by Tavneos. Among the injuries were seven cases of vanishing bile duct syndrome, which is a rare condition that can lead to permanent liver damage.
Tavneos is a medical treatment approved to treat anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, which is a group of rare autoimmune diseases that inflame small- to medium-sized blood vessels.
Illinois Injury and Mass Tort Lawyer Blog


Recently, 4our Kiddies tip restraint kits, which include plastic tip restraints, were
The Cartiva Synthetic Cartilage Implant (Cartiva SCI) is a hydrogel implant created to treat painful toe arthritis at the big toe’s base. Recently, plaintiffs in five lawsuits moved under 28 U.S.C. section 1407 to
The FDA has reported that, based on medical device maker Abbott Laboratory’s company data, there have been 860 serious injuries connected to the recall of certain glucose monitoring sensors. Internal testing at the manufacturer determined that certain sensors can offer
The Food and Drug Administration (FDA) has announced its
A San Jose, California-based manufacturer of cookware items, IKM, is
Recently, Nestlé expanded its
Recently, Clorox agreed it would pay a
Recently, Navitas Organics voluntarily
On December 18, 2025, Plantimex, the manufacturer,